Options
Cancer Biology and Medicine Volume 20
ISSN
20953941
Date Issued
2023
Abstract
(Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer - https://doi.org/10.20892/j.issn.2095-3941.2023.0286) -
(Immunotherapy for multiple myeloma: new chances and hope - https://doi.org/10.20892/j.issn.2095-3941.2023.0258) -
(Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma - https://doi.org/10.20892/j.issn.2095-3941.2023.0189) -
(Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy - https://doi.org/10.20892/j.issn.2095-3941.2023.0232) -
(Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment - https://doi.org/10.20892/j.issn.2095-3941.2023.0284)
(Immunotherapy for multiple myeloma: new chances and hope - https://doi.org/10.20892/j.issn.2095-3941.2023.0258) -
(Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma - https://doi.org/10.20892/j.issn.2095-3941.2023.0189) -
(Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy - https://doi.org/10.20892/j.issn.2095-3941.2023.0232) -
(Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment - https://doi.org/10.20892/j.issn.2095-3941.2023.0284)
File(s)